Consistently, Erlotinib was more effective against U251-SCD (with higher EGFR expression) compared to control U251 cells (Fig. 4G), while erlotinib was less effective against U87-SCD (with lower EGFR) compared to control U87 cells (Fig. 4H). This evidence concerns the gene EGFR and Schnyder corneal dystrophy.